Gummow Brian M, Scheys Joshua O, Cancelli Victoria R, Hammer Gary D
University of Michigan Medical School, Department of Molecular and Integrative Physiology, Ann Arbor, Michigan 48109-2200, USA.
Mol Endocrinol. 2006 Nov;20(11):2711-23. doi: 10.1210/me.2005-0461. Epub 2006 Jul 20.
Numerous genes required for adrenocortical steroidogenesis are activated by the nuclear hormone receptor steroidogenic factor 1 (SF-1) (NR5A1). Dax-1 (NR0B1), another nuclear hormone receptor, represses SF-1-dependent activation. Glucocorticoid products of the adrenal cortex provide negative feedback to the production of hypothalamic CRH and pituitary ACTH. We hypothesized that glucocorticoids stimulate an intraadrenal negative feedback loop via activation of Dax-1 expression. Reporter constructs show glucocorticoid-dependent synergy between SF-1 and glucocorticoid receptor (GR) in the activation of Dax-1, which is antagonized by ACTH signaling. We map the functional glucocorticoid response element between -718 and -704 bp, required for activation by GR and synergy with SF-1. Of three SF-1 response elements, only the -128-bp SF-1 response element is required for synergy with GR. Chromatin immunoprecipitation (ChIP) assays demonstrate that dexamethasone treatment increases GR and SF-1 binding to the endogenous murine Dax-1 promoter 10- and 3.5-fold over baseline. Serial ChIP assays reveal that that GR and SF-1 are part of the same complex on the Dax-1 promoter, whereas coimmunoprecipitation assay confirms the presence of a protein complex that contains both GR and SF-1. ACTH stimulation disrupts the formation of this complex by abrogating SF-1 binding to the Dax-1 promoter, while promoting SF-1 binding to the melanocortin-2 receptor (Mc2r) and steroidogenic acute regulatory protein (StAR) promoters. Finally, dexamethasone treatment increases endogenous Dax-1 expression and concordantly decreases StAR expression. ACTH signaling antagonizes the increase in Dax-1 yet strongly activates StAR transcription. These data indicate that GR provides feedback regulation of adrenocortical steroid production through synergistic activation of Dax-1 with SF-1, which is antagonized by ACTH activation of the adrenal cortex.
肾上腺皮质类固醇生成所需的众多基因由核激素受体类固醇生成因子1(SF-1,NR5A1)激活。另一种核激素受体Dax-1(NR0B1)则抑制SF-1依赖性激活。肾上腺皮质的糖皮质激素产物对下丘脑促肾上腺皮质激素释放激素(CRH)和垂体促肾上腺皮质激素(ACTH)的产生提供负反馈。我们推测糖皮质激素通过激活Dax-1表达刺激肾上腺内负反馈回路。报告基因构建体显示,在Dax-1激活过程中,SF-1与糖皮质激素受体(GR)之间存在糖皮质激素依赖性协同作用,而ACTH信号传导可拮抗这种作用。我们确定了-718至-704 bp之间的功能性糖皮质激素反应元件,这是GR激活以及与SF-1协同作用所必需的。在三个SF-1反应元件中,只有-128 bp的SF-1反应元件是与GR协同作用所必需的。染色质免疫沉淀(ChIP)分析表明,地塞米松处理使GR和SF-1与内源性小鼠Dax-1启动子的结合比基线增加了10倍和3.5倍。连续ChIP分析显示,GR和SF-1是Dax-1启动子上同一复合物的一部分,而免疫共沉淀分析证实存在同时包含GR和SF-1的蛋白质复合物。ACTH刺激通过消除SF-1与Dax-1启动子的结合来破坏该复合物的形成,同时促进SF-1与促黑素细胞激素-2受体(Mc2r)和类固醇生成急性调节蛋白(StAR)启动子的结合。最后,地塞米松处理增加内源性Dax-1表达,并相应降低StAR表达。ACTH信号传导拮抗Dax-1的增加,但强烈激活StAR转录。这些数据表明,GR通过与SF-1协同激活Dax-1来提供对肾上腺皮质类固醇生成的反馈调节,而肾上腺皮质的ACTH激活可拮抗这种作用。